Primjeri korištenja Were administered na Engleski i njihovi prijevodi na Hrvatskom
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
The first doses were administered at 11.00 hours.
In the pivotal trial(BO16216)Herceptin and anastrozole were administered from day 1.
Both regimens were administered every 3 weeks.
The total dose was divided between the selected muscles and 1 to 5 injections per muscle were administered.
Vaccines were administered at 1 month intervals.
Other therapies, such as heparin andGPIIb/IIIa inhibitors, were administered at the discretion of the physician.
Both regimens were administered once every 3 weeks for 6 cycles.
During controlled clinical trials in healthy subjects, single doses of up to 800 mg sitagliptin were administered.
Simponi or placebo were administered subcutaneously every 4 weeks.
In each treatment cycle, two injections of Xiapex 0.58 mg or two injections of placebo were administered 1 to 3 days apart.
Both regimens were administered on day 1 every 3 weeks.
Two doses of vaccine with H5N3(A/Duck/Singapore/97)strain at 3 different dosages(7.5, 15 and 30 µg HA/dose) were administered three weeks apart.
All treatment cycles were administered at intervals of 3 weeks.
In a total of twenty-three clinical trials, approximately 106000 doses of Rotarix(lyophilised orliquid formulation) were administered to approximately 51000 infants.
Growth factors were administered to 19% of patients in 8% of courses.
Two doses of vaccine containing H5N1(A/Vietnam/1194/2004; 7.5 µg HA/dose adjuvanted) were administered three weeks apart to 156 healthy adults.
Oxaliplatin-based regimens were administered in combination with bevacizumab in 373 patients 30.4.
Embryofetal studies in rat and rabbit; Daily single doses of vehicle or625 U/kg/administration of rhC1INH were administered intravenously to mated rats and rabbits.
ISENTRESS and efavirenz were administered with emtricitabine(+) tenofovir.
Decreased MPA exposure has been observed when antacids, such as magnesium and aluminium hydroxides, and PPIs,including lansoprazole and pantoprazole, were administered with mycophenolate mofetil.
Doxorubicin and cyclophosphamide were administered concurrently as follows.
Patients were administered Enzepi at the same dose they were taking at the end of Study PR-011.
Over 94,000 doses of DUKORAL were administered during the clinical trials.
Infusions were administered, 272(in 16 patients) in the 3-week schedule and 766(in 64 patients) in the 4-week schedule.
Adjuvant corticosteroids, including dexamethasone, were administered with chemotherapy in 55% of patients.
Infusions were administered and the median dose administered was 492.3 mg IgG/kg bw.
In clinical trials, the majority of patients were administered antihistamines and topical corticosteroids.
Treatments were administered for three cycles of 28 days on therapy followed by 28 days off therapy.
Raltegravir and efavirenz were administered with emtricitabine(+) tenofovir.
Patients were administered at least two nucleoside/nucleotide reverse transcriptase inhibitors selected by the investigator.
